Dr. Janika Viereck, PhD

Head of R&D at Cardior Pharmaceuticals GmbH - a Novo Nordisk company

Speaker

Janika Viereck is Head of Research and Development at Cardior Pharmaceuticals GmbH, a Novo Nordisk company, where she is responsible for the early and preclinical development of ncRNA- and oligonucleotide-based therapeutics and diagnostics. During her PhD and Postdoc at the Hannover Medical School, Germany she researched long non-coding RNAs and microRNAs as potential drug as well as diagnostic targets for the treatment and diagnosis of cardiovascular disease. She developed antisense oligonucleotide and RNA replacement therapeutics to modulate non-coding RNA function. She gained her MS in biotechnology from the TU Braunschweig, Germany. Janika has more than 10 years of experience in the fields of non-coding RNA therapeutics, diagnostics, and cardiovascular disease.